• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.使用患者来源的诱导多能干细胞来鉴定帕金森病相关表型。
Curr Neurol Neurosci Rep. 2018 Oct 4;18(12):84. doi: 10.1007/s11910-018-0893-8.
2
Parkinson's disease in a dish - Using stem cells as a molecular tool.在培养皿中研究帕金森病——以干细胞为分子工具。
Neuropharmacology. 2014 Jan;76 Pt A:88-96. doi: 10.1016/j.neuropharm.2013.08.035. Epub 2013 Sep 10.
3
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.帕金森病相关蛋白Parkin和PINK1患者诱导多能干细胞衍生的中脑多巴胺能神经元表现出线粒体功能障碍和α-突触核蛋白积聚。
Stem Cell Reports. 2016 Oct 11;7(4):664-677. doi: 10.1016/j.stemcr.2016.08.012. Epub 2016 Sep 15.
4
Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.在基于人诱导多能干细胞的家族性帕金森病模型中展示大脑区域特定神经元易损性。
Hum Mol Genet. 2020 May 8;29(7):1180-1191. doi: 10.1093/hmg/ddaa039.
5
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.帕金森病患者(PARK4)中 SNCA 三重复制诱导多能干细胞源性多巴胺能神经元中的α-突触核蛋白动力学。
FEBS Open Bio. 2021 Feb;11(2):354-366. doi: 10.1002/2211-5463.13060. Epub 2021 Jan 5.
6
SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.SNCA 三重复制帕金森病患者的 iPSC 衍生的 DA 神经元积累α-突触核蛋白,并易受氧化应激影响。
PLoS One. 2011;6(11):e26159. doi: 10.1371/journal.pone.0026159. Epub 2011 Nov 16.
7
Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.利用患者特异性诱导多能干细胞建立帕金森病模型。
J Parkinsons Dis. 2018;8(4):479-493. doi: 10.3233/JPD-181353.
8
Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.家族性帕金森病患者诱导多能干细胞衍生的多巴胺能神经元显示α-突触核蛋白病理学和异常的线粒体形态。
Cells. 2021 Sep 13;10(9):2402. doi: 10.3390/cells10092402.
9
Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.从帕金森病患者中生成嗜幼稚型诱导多能干细胞用于高效基因操作和疾病建模。
Stem Cells Dev. 2015 Nov 1;24(21):2591-604. doi: 10.1089/scd.2015.0079. Epub 2015 Sep 1.
10
Modeling Parkinson's disease using induced pluripotent stem cells.利用诱导多能干细胞来模拟帕金森病。
Curr Neurol Neurosci Rep. 2012 Jun;12(3):237-42. doi: 10.1007/s11910-012-0270-y.

引用本文的文献

1
Low-frequency genetic variants in GAK enhance Golgi function and protect against Parkinson's disease.GAK基因中的低频遗传变异增强高尔基体功能并预防帕金森病。
medRxiv. 2025 Aug 15:2025.08.13.25333123. doi: 10.1101/2025.08.13.25333123.
2
Proteomic insights into the biology of dopaminergic neurons.对多巴胺能神经元生物学的蛋白质组学见解。
Front Mol Neurosci. 2025 Jul 30;18:1642519. doi: 10.3389/fnmol.2025.1642519. eCollection 2025.
3
Cell therapy for neurological disorders.细胞治疗神经系统疾病。
Nat Med. 2024 Oct;30(10):2756-2770. doi: 10.1038/s41591-024-03281-3. Epub 2024 Oct 15.
4
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress.帕金森病中的“疯狂三联征”:代谢改变、α-突触核蛋白聚集与氧化应激。
Mol Cell Biochem. 2025 Jan;480(1):139-157. doi: 10.1007/s11010-024-04985-3. Epub 2024 Apr 16.
5
Attenuates Antioxidant Response in Familial Parkinson's Disease Derived Neural Stem Cells.减弱家族性帕金森病来源神经干细胞的抗氧化反应。
Cells. 2023 Oct 31;12(21):2550. doi: 10.3390/cells12212550.
6
Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons.器官芯片增强人诱导多能干细胞衍生的多巴胺神经元的成熟。
Int J Mol Sci. 2023 Sep 18;24(18):14227. doi: 10.3390/ijms241814227.
7
Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders.基于干细胞的治疗:治疗神经紊乱的天赐武器。
Cells. 2022 Nov 2;11(21):3476. doi: 10.3390/cells11213476.
8
P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration.P97/VCP ATP酶抑制剂可挽救与p97突变相关的运动神经元变性。
Brain Commun. 2022 Jul 6;4(4):fcac176. doi: 10.1093/braincomms/fcac176. eCollection 2022.
9
Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.诱导多能干细胞作为建模血液系统疾病的工具和细胞治疗的潜在来源。
Cells. 2021 Nov 19;10(11):3250. doi: 10.3390/cells10113250.
10
Understanding the Potential of Genome Editing in Parkinson's Disease.理解基因组编辑在帕金森病中的潜力。
Int J Mol Sci. 2021 Aug 26;22(17):9241. doi: 10.3390/ijms22179241.

本文引用的文献

1
α-Synucleins from Animal Species Show Low Fibrillation Propensities and Weak Oligomer Membrane Disruption.来自动物物种的α-突触核蛋白显示出低纤维化倾向和较弱的寡聚体膜破坏能力。
Biochemistry. 2018 Aug 28;57(34):5145-5158. doi: 10.1021/acs.biochem.8b00627. Epub 2018 Aug 15.
2
Determinants of dopaminergic neuron loss in Parkinson's disease.帕金森病中多巴胺能神经元丧失的决定因素。
FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14.
3
Prevalence of Parkinson's disease across North America.北美帕金森病的患病率。
NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.
4
Gene Editing on Center Stage.基因编辑站上舞台中央。
Trends Genet. 2018 Aug;34(8):600-611. doi: 10.1016/j.tig.2018.05.004. Epub 2018 Jun 13.
5
A single cell high content assay detects mitochondrial dysfunction in iPSC-derived neurons with mutations in SNCA.单细胞高内涵分析检测到携带 SNCA 突变的 iPSC 源性神经元中线粒体功能障碍。
Sci Rep. 2018 Jun 13;8(1):9033. doi: 10.1038/s41598-018-27058-0.
6
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease.α-突触核蛋白寡聚体与 ATP 合酶相互作用并在帕金森病中打开通透性转换孔。
Nat Commun. 2018 Jun 12;9(1):2293. doi: 10.1038/s41467-018-04422-2.
7
The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.烟酰胺核苷(NAD+ 的前体)可挽救帕金森病 iPSC 和果蝇模型中的线粒体缺陷和神经元缺失。
Cell Rep. 2018 Jun 5;23(10):2976-2988. doi: 10.1016/j.celrep.2018.05.009.
8
Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach.基于三方比较的帕金森病基因共表达网络分析——寻找遗传标记物。
Genomics. 2019 Jul;111(4):819-830. doi: 10.1016/j.ygeno.2018.05.005. Epub 2018 May 28.
9
Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.可溶性环氧化物水解酶在帕金森病的发病机制中起关键作用。
Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5815-E5823. doi: 10.1073/pnas.1802179115. Epub 2018 May 7.
10
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance.影响线粒体健康和帕金森病外显率的环境与遗传变量
Parkinsons Dis. 2018 Mar 7;2018:8684906. doi: 10.1155/2018/8684906. eCollection 2018.

使用患者来源的诱导多能干细胞来鉴定帕金森病相关表型。

Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

机构信息

Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, BSB 409, 8701 Watertown Plank Rd, Milwaukee, WI, 53226, USA.

Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, 53705, USA.

出版信息

Curr Neurol Neurosci Rep. 2018 Oct 4;18(12):84. doi: 10.1007/s11910-018-0893-8.

DOI:10.1007/s11910-018-0893-8
PMID:30284665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6739862/
Abstract

PURPOSE OF REVIEW

Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting older individuals. The specific cause underlying dopaminergic (DA) neuron loss in the substantia nigra, a pathological hallmark of PD, remains elusive. Here, we highlight peer-reviewed reports using induced pluripotent stem cells (iPSCs) to model PD in vitro and discuss the potential disease-relevant phenotypes that may lead to a better understanding of PD etiology. Benefits of iPSCs are that they retain the genetic background of the donor individual and can be differentiated into specialized neurons to facilitate disease modeling.

RECENT FINDINGS

Mitochondrial dysfunction, oxidative stress, ER stress, and alpha-synuclein accumulation are common phenotypes observed in PD iPSC-derived neurons. New culturing technologies, such as directed reprogramming and midbrain organoids, offer innovative ways of investigating intraneuronal mechanisms of PD pathology. PD patient-derived iPSCs are an evolving resource to understand PD pathology and identify therapeutic targets.

摘要

综述目的:帕金森病(PD)是影响老年人的第二大常见神经退行性疾病。导致黑质多巴胺(DA)神经元丧失的具体原因仍然难以捉摸,这是 PD 的一个病理标志。在这里,我们重点介绍了使用诱导多能干细胞(iPSCs)在体外模拟 PD 的同行评审报告,并讨论了可能导致更好地了解 PD 病因的潜在与疾病相关的表型。iPSCs 的优点是它们保留了供体个体的遗传背景,并可分化为专门的神经元,以促进疾病建模。

最新发现:在 PD iPSC 衍生神经元中观察到线粒体功能障碍、氧化应激、内质网应激和α-突触核蛋白积累等常见表型。定向重编程和中脑神经器官等新的培养技术为研究 PD 病理学的神经元内机制提供了创新方法。PD 患者来源的 iPSCs 是理解 PD 病理学和确定治疗靶点的不断发展的资源。